Principal Investigator
Gerald Soff
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230752
Clinical Trial Summary
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Avatrombopag for Persistent Chemotherapy-Induced Thrombocytopenia in Patients with Gastrointestinal Malignancies
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Leukemia
Contact Information
Phone Number
305-243-2647